ESSA Pharma Inc (EPIX)
1.82
+0.06
(+3.41%)
USD |
NASDAQ |
Nov 22, 13:27
ESSA Pharma Net Income (Quarterly): -7.234M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -7.234M |
| March 31, 2024 | -8.990M |
| December 31, 2023 | -5.964M |
| September 30, 2023 | -5.481M |
| June 30, 2023 | -7.299M |
| March 31, 2023 | -7.060M |
| December 31, 2022 | -6.742M |
| September 30, 2022 | -6.324M |
| June 30, 2022 | -8.827M |
| March 31, 2022 | -10.85M |
| December 31, 2021 | -9.098M |
| September 30, 2021 | -8.560M |
| June 30, 2021 | -8.752M |
| March 31, 2021 | -12.97M |
| December 31, 2020 | -6.529M |
| September 30, 2020 | -4.553M |
| June 30, 2020 | -4.925M |
| March 31, 2020 | -9.354M |
| December 31, 2019 | -4.613M |
| September 30, 2019 | -3.314M |
| June 30, 2019 | -3.302M |
| March 31, 2019 | -3.430M |
| Date | Value |
|---|---|
| December 31, 2018 | -2.71M |
| September 30, 2018 | -2.276M |
| June 30, 2018 | -2.880M |
| March 31, 2018 | -4.383M |
| December 31, 2017 | -2.090M |
| September 30, 2017 | -1.945M |
| June 30, 2017 | 3.592M |
| March 31, 2017 | -7.611M |
| December 31, 2016 | 1.464M |
| September 30, 2016 | -4.237M |
| June 30, 2016 | -3.866M |
| March 31, 2016 | -1.052M |
| December 31, 2015 | -3.985M |
| September 30, 2015 | 0.4877M |
| June 30, 2015 | -5.289M |
| March 31, 2015 | -3.550M |
| December 31, 2014 | -1.326M |
| September 30, 2014 | -0.4687M |
| June 30, 2014 | -0.9814M |
| March 31, 2014 | -0.1379M |
| December 31, 2013 | -0.2314M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-12.97M
Minimum
Mar 2021
-4.553M
Maximum
Sep 2020
-7.586M
Average
-7.234M
Median
Jun 2024
Net Income (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 14.35M |
| Edesa Biotech Inc | -1.668M |
| Lexaria Bioscience Corp | -1.782M |
| Xenon Pharmaceuticals Inc | -62.79M |
| ImmunoPrecise Antibodies Ltd | -2.920M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.884M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | -52.60M |
| Earnings Yield | -34.07% |